Manufacturing
Facilities
An organisations’ capabilities and intent are strongly
reflected in the product it manufactures. In other words,
the manufacturing competencies and facilities echo truly,
the R&D extent and the ability to implement it for the
best of the market it targets.
RANBAXY® possesses the manufacturing strengths that have established it as a producer of world-class generics, branded generics and a major supplier of its range of Active Pharmaceutical Ingredients for pharmaceutical products of companies worldwide.
Ranbaxy has world-class manufacturing facilities in 11 countries namely Brazil, China, Ireland, India, Japan, Malaysia, Nigeria, Romania, South Africa, USA and Vietnam. Its overseas facilities are designed
to cater to the requirements of the local regulatory bodies
of that country while the Indian facilities meet the requirements
of all International Regulatory Agencies.
Some of the agencies such as MCA-UK, MCC-South Africa,
FDA-USA and TGA-Australia, have audited
and approved Ranbaxy’s manufacturing
facilities for the compliance with international Good Manufacturing
Practices and have registered its products for safety,
quality and efficacy.